Mandip S. Dhamoon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mandip S. Dhamoon has a total of 191 co-authors. Here are the top co-authors by number of shared publications:
- Laura Katherine Stein
Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, USA
13 shared publications Ralph L. Sacco
McKnight Brain Institute, Miller School of Medicine, University of Miami, Miami, Florida
9 shared publicationsStanley Tuhrim
Department of Neurology (L.K.S., J.F., N.J., S.T., M.S.D.), Icahn School of Medicine at Mount Sinai, NY
9 shared publicationsDavid Daniel
Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY (S.P.P., D.D., M.S.D.).
8 shared publicationsMitchell S.V. Elkind
Department of Epidemiology, College of Physicians and Surgeons, Mailman School of Public Health, Columbia University, New York, New York
7 shared publicationsYing-Kuen Cheung
Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, United States of America
6 shared publications
Latest Publications
- 1 October 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (10) , 2957-2965
Associations Between Measures of Structural Racism and Acute Ischemic Stroke Outcomes in the United States
BACKGROUND: Structural inequity, including structural racism, is linked to stroke measures. Prior work showed that ecosocial models quantifying constituent domains of structural racism are associated with acute ischemic stroke incidence. It remains unclear if such models can further account for the not-yet-fully explained racial disparities in stroke outcomes. METHODS: We performed a national, population-based analysis of 71 078 619 Medicare beneficiaries aged ≥65 years enrolled in Medicare from January 1, 2016 to December 31, 2019 of whom 844 406 had a primary diagnosis of acute ischemic stroke. We estimated the odds ratio and 95% CIs of 3 outcomes (inpatient mortality, 30-day mortality, and discharge home) using multilevel logistic models, with data clustered at the county level. County-level data from the US Census Bureau and Home Mortgage Disclosure Act were used to calculate 8 measures of structural racism. These were tested separately and as a summed, normally distributed composite structural racism score for associations with the outcomes, adjusting for sex, age, urban versus other location, and Black versus White race. RESULTS: For each SD increase in the composite structural racism score, there was a 16% increase in poststroke inpatient mortality for the total population (odds ratio, 1.160 [95% CI, 1.10–1.215]) without a significant interaction with race ( P =0.624). Both 30-day all-cause mortality ( P =0.035) and odds of discharge home ( P =0.023) significantly interacted with race. For each SD increase in the composite score, Black individuals had a 4.5% increased odds of 30-day mortality and a 5.8% decreased odds of being discharged home, whereas White patients had a 6.5% increase in 30-day mortality and a 3.5% decrease in odds of discharge home. CONCLUSIONS: Increasing levels of structural racism, as calculated using validated quantitative measures of an ecosocial model of structural racism, are correlated with increasing poststroke mortality and decreased odds of discharge home, regardless of race.
- 1 October 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (10) , 2957-2965
Associations Between Measures of Structural Racism and Acute Ischemic Stroke Outcomes in the United States
BACKGROUND: Structural inequity, including structural racism, is linked to stroke measures. Prior work showed that ecosocial models quantifying constituent domains of structural racism are associated with acute ischemic stroke incidence. It remains unclear if such models can further account for the not-yet-fully explained racial disparities in stroke outcomes. METHODS: We performed a national, population-based analysis of 71 078 619 Medicare beneficiaries aged ≥65 years enrolled in Medicare from January 1, 2016 to December 31, 2019 of whom 844 406 had a primary diagnosis of acute ischemic stroke. We estimated the odds ratio and 95% CIs of 3 outcomes (inpatient mortality, 30-day mortality, and discharge home) using multilevel logistic models, with data clustered at the county level. County-level data from the US Census Bureau and Home Mortgage Disclosure Act were used to calculate 8 measures of structural racism. These were tested separately and as a summed, normally distributed composite structural racism score for associations with the outcomes, adjusting for sex, age, urban versus other location, and Black versus White race. RESULTS: For each SD increase in the composite structural racism score, there was a 16% increase in poststroke inpatient mortality for the total population (odds ratio, 1.160 [95% CI, 1.10–1.215]) without a significant interaction with race ( P =0.624). Both 30-day all-cause mortality ( P =0.035) and odds of discharge home ( P =0.023) significantly interacted with race. For each SD increase in the composite score, Black individuals had a 4.5% increased odds of 30-day mortality and a 5.8% decreased odds of being discharged home, whereas White patients had a 6.5% increase in 30-day mortality and a 3.5% decrease in odds of discharge home. CONCLUSIONS: Increasing levels of structural racism, as calculated using validated quantitative measures of an ecosocial model of structural racism, are correlated with increasing poststroke mortality and decreased odds of discharge home, regardless of race.
- 22 April 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (8) , e213413
Associations Between Measures of Structural Racism and Acute Ischemic Stroke Incidence in the United States
Racial differences in socioeconomic characteristics are believed to be secondary to structural racism. While socioeconomic factors explain some of the racial disparity in stroke incidence at an individual level, little is known about the association between societal-level structural racism and incidence of acute ischemic stroke (AIS). We aimed to determine whether the geographic racial disparity in stroke incidence across the United States is associated with structural racism. We performed a national, population-based analysis of 71,078,619 adults (844,406 with incident AIS) aged 65 years and older who were enrolled in Medicare from January 1, 2016, to December 31, 2019. The primary exposure was a composite score calculated from 8 county-level measures of structural racism (segregation indices [delta, dissimilarity, isolation], Gini index, housing discrimination, educational attainment, employment, and income) that account for validated domains of structural racism based on an ecosocial model. The primary outcome was incident AIS. Marginal Cox models with data clustered at the county level were used to estimate the hazard ratio (HR) of AIS incidence, comparing Black individuals with White individuals. Separate marginal Cox models tested associations between each measure of structural racism and AIS incidence, with further testing to screen for interaction with the race variable. The composite structural racism score identified significant geographic variation in structural racism across the United States (mean 0.818, SD 2.874, interquartile range 3.02). Black individuals had a 19% increased hazard of AIS compared with White individuals (HR 1.19, 95% CI 1.14-1.25, p < 0.0001). All constituent measures of structural racism, except for housing discrimination, were associated with AIS incidence independently of race. Each SD increase in the composite structural racism score was associated with an 18% increased incidence in AIS in the total population. This association interacted with race (p = 0.03), with a greater magnitude of association for White (HR 1.19, 95% CI 1.13-1.25, p < 0.0001) vs Black (HR 1.09, 95% CI 1.03-1.16, p = 0.0073) individuals. There is significant county-level geographic variation in structural racism across the United States, and increasing levels of structural racism are associated with increased incidence of AIS, regardless of race.
- 22 April 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (8) , e213413
Associations Between Measures of Structural Racism and Acute Ischemic Stroke Incidence in the United States
Racial differences in socioeconomic characteristics are believed to be secondary to structural racism. While socioeconomic factors explain some of the racial disparity in stroke incidence at an individual level, little is known about the association between societal-level structural racism and incidence of acute ischemic stroke (AIS). We aimed to determine whether the geographic racial disparity in stroke incidence across the United States is associated with structural racism. We performed a national, population-based analysis of 71,078,619 adults (844,406 with incident AIS) aged 65 years and older who were enrolled in Medicare from January 1, 2016, to December 31, 2019. The primary exposure was a composite score calculated from 8 county-level measures of structural racism (segregation indices [delta, dissimilarity, isolation], Gini index, housing discrimination, educational attainment, employment, and income) that account for validated domains of structural racism based on an ecosocial model. The primary outcome was incident AIS. Marginal Cox models with data clustered at the county level were used to estimate the hazard ratio (HR) of AIS incidence, comparing Black individuals with White individuals. Separate marginal Cox models tested associations between each measure of structural racism and AIS incidence, with further testing to screen for interaction with the race variable. The composite structural racism score identified significant geographic variation in structural racism across the United States (mean 0.818, SD 2.874, interquartile range 3.02). Black individuals had a 19% increased hazard of AIS compared with White individuals (HR 1.19, 95% CI 1.14-1.25, p < 0.0001). All constituent measures of structural racism, except for housing discrimination, were associated with AIS incidence independently of race. Each SD increase in the composite structural racism score was associated with an 18% increased incidence in AIS in the total population. This association interacted with race (p = 0.03), with a greater magnitude of association for White (HR 1.19, 95% CI 1.13-1.25, p < 0.0001) vs Black (HR 1.09, 95% CI 1.03-1.16, p = 0.0073) individuals. There is significant county-level geographic variation in structural racism across the United States, and increasing levels of structural racism are associated with increased incidence of AIS, regardless of race.
- Open Access
- 1 April 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (7) , e037125
Associations Between Measures of Structural Racism and Receipt of Acute Ischemic Stroke Interventions in the United States
Background: Structural racism and rural/urban differences in stroke care affect care delivery and outcomes. We explored the interplay among structural racism, urbanity, and intravenous thrombolysis (tissue plasminogen activator) and endovascular thrombectomy (ET). Methods and Results: In this retrospective study using complete, deidentified inpatient Medicare data (2016–2019), we identified incident acute ischemic stroke admissions, demographics, and hospital‐level variables. Medicare beneficiaries aged ≥65 years with incident acute ischemic stroke admission in large metropolitan and nonurban settings were included. Validated structural racism metrics at the county level and a composite structural racism score that incorporated measures of segregation, housing, employment, education, and income were studied. Among 951 914 patients, rural hospitals demonstrated lower intensive care unit capacity (27.5% versus 88.6%), stroke certification (5.3% versus 38.4%), and rates of tissue plasminogen activator (1.6% versus 12.3%) and ET (<1% versus 3.8%). Large metropolitan areas demonstrated higher levels of income inequality (Gini index −0.15 versus 0.11 SD), and racial segregation (dissimilarity index 0.29 SD higher than the US mean). The composite structural racism score was associated with increased odds of tissue plasminogen activator receipt (odds ratio, 1.47 [95% CI, 1.33–1.63]) and ET (odds ratio, 4.15 [95% CI, 2.98–5.79]). Despite greater access to stroke care in urban areas, a persistent racial disparity remained, with Black patients less likely to receive tissue plasminogen activator (odds ratio, 0.70 [95% CI, 0.68–0.72]) and ET (odds ratio, 0.63 [95% CI, 0.60–0.66]) compared with White patients. Conclusions: We found persistent disparities in stroke care access and outcomes, influenced by structural racism and rural–urban differences. Further research should explore interactions between structural racism, urbanity, and health care delivery to inform effective interventions.
- 1 April 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (7) , e037125
Open AccessAssociations Between Measures of Structural Racism and Receipt of Acute Ischemic Stroke Interventions in the United States
Background: Structural racism and rural/urban differences in stroke care affect care delivery and outcomes. We explored the interplay among structural racism, urbanity, and intravenous thrombolysis (tissue plasminogen activator) and endovascular thrombectomy (ET). Methods and Results: In this retrospective study using complete, deidentified inpatient Medicare data (2016–2019), we identified incident acute ischemic stroke admissions, demographics, and hospital‐level variables. Medicare beneficiaries aged ≥65 years with incident acute ischemic stroke admission in large metropolitan and nonurban settings were included. Validated structural racism metrics at the county level and a composite structural racism score that incorporated measures of segregation, housing, employment, education, and income were studied. Among 951 914 patients, rural hospitals demonstrated lower intensive care unit capacity (27.5% versus 88.6%), stroke certification (5.3% versus 38.4%), and rates of tissue plasminogen activator (1.6% versus 12.3%) and ET (<1% versus 3.8%). Large metropolitan areas demonstrated higher levels of income inequality (Gini index −0.15 versus 0.11 SD), and racial segregation (dissimilarity index 0.29 SD higher than the US mean). The composite structural racism score was associated with increased odds of tissue plasminogen activator receipt (odds ratio, 1.47 [95% CI, 1.33–1.63]) and ET (odds ratio, 4.15 [95% CI, 2.98–5.79]). Despite greater access to stroke care in urban areas, a persistent racial disparity remained, with Black patients less likely to receive tissue plasminogen activator (odds ratio, 0.70 [95% CI, 0.68–0.72]) and ET (odds ratio, 0.63 [95% CI, 0.60–0.66]) compared with White patients. Conclusions: We found persistent disparities in stroke care access and outcomes, influenced by structural racism and rural–urban differences. Further research should explore interactions between structural racism, urbanity, and health care delivery to inform effective interventions.
- Open Access
A Machine Learning Prediction Model to Identify Individuals at Risk of 5-Year Incident Stroke Based on Retinal Imaging
Stroke is a leading cause of death and disability in developed countries. We validated an AI-based prediction model for incident stroke using sensors such as fundus cameras and ophthalmoscopes for retinal images, along with socio-demographic data and traditional risk factors. The model was trained on a proprietary dataset of over 6500 participants, including 171 with 5-year incident strokes and 242 with 10-year incident strokes. The model provides separate 5-year and 10-year risk scores. The model was externally validated on the UK Biobank dataset (3000 subjects with 5-year incident strokes). Using retinal imaging, our models identified individuals with 5-year incident strokes with 80% sensitivity, 82% specificity, and an AUC of 0.83, and predicted 10-year incidents with 72% sensitivity, 78% specificity, and an AUC of 0.79. In comparison, for the 10-year model, the AUC for the Framingham score was 0.73, and the CHADS2 score was 0.74. On the Biobank external dataset, our 5-year model (without retinal features) demonstrated moderate but lower sensitivity (69.3%) and specificity (66.4%) compared to its performance on the proprietary dataset (with retinal features). Using a multi-ethnic dataset, we developed and validated a prediction model that improves stroke risk identification for 5-year and 10-year incidences by incorporating retinal features.
Open AccessA Machine Learning Prediction Model to Identify Individuals at Risk of 5-Year Incident Stroke Based on Retinal Imaging
Stroke is a leading cause of death and disability in developed countries. We validated an AI-based prediction model for incident stroke using sensors such as fundus cameras and ophthalmoscopes for retinal images, along with socio-demographic data and traditional risk factors. The model was trained on a proprietary dataset of over 6500 participants, including 171 with 5-year incident strokes and 242 with 10-year incident strokes. The model provides separate 5-year and 10-year risk scores. The model was externally validated on the UK Biobank dataset (3000 subjects with 5-year incident strokes). Using retinal imaging, our models identified individuals with 5-year incident strokes with 80% sensitivity, 82% specificity, and an AUC of 0.83, and predicted 10-year incidents with 72% sensitivity, 78% specificity, and an AUC of 0.79. In comparison, for the 10-year model, the AUC for the Framingham score was 0.73, and the CHADS2 score was 0.74. On the Biobank external dataset, our 5-year model (without retinal features) demonstrated moderate but lower sensitivity (69.3%) and specificity (66.4%) compared to its performance on the proprietary dataset (with retinal features). Using a multi-ethnic dataset, we developed and validated a prediction model that improves stroke risk identification for 5-year and 10-year incidences by incorporating retinal features.
- 1 January 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (1) , 122-127
Hypoglycemic Events May Trigger Acute Ischemic Stroke Within 30 Days in Those With Diabetes: A Case-Crossover Study
BACKGROUND: Stroke triggers are factors that may precipitate a stroke within a given time interval and can predict the timing of a stroke. While hypoglycemia has been established as a risk factor for cardiovascular events such as acute ischemic stroke (AIS), there is limited research demonstrating hypoglycemic events as stroke triggers. We hypothesize an association between hypoglycemic events and the occurrence of stroke among patients with diabetes. METHODS: We used Medicare inpatient, outpatient, emergency department, and subacute nursing facility data sets from January 1, 2016, to December 31, 2019, and validated using International Classification of Diseases , Tenth Revision , Clinical Modification codes to identify conditions. We used a case-crossover study design, testing whether exposure to a hypoglycemia encounter within progressively longer case periods (up to 30 days before index AIS) was associated with the subsequent occurrence of AIS, compared with control periods of equal length exactly 1 year before the case period. We used conditional logistical regression models to estimate odds ratios and 95% CIs. RESULTS: There were 237 667 index admissions with AIS and diabetes during the study period. There were increased odds of AIS following an encounter with hypoglycemia. The risk was the highest immediately on the first day following the hypoglycemia encounter (odds ratio, 3.694 [95% CI, 2.694–5.065]; P P <0.0001). CONCLUSIONS: We found that hypoglycemic events in patients with diabetes are associated with a more than 3-fold greater risk of AIS in the first day but can trigger AIS in the 30 days following the event. More research is needed to assess the link between the severity of hypoglycemia and stroke occurrence, as well as the severity of the stroke. These results, if confirmed in other studies, emphasize the importance of avoiding hypoglycemic events in patients with diabetes.
- 1 January 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (1) , 122-127
Hypoglycemic Events May Trigger Acute Ischemic Stroke Within 30 Days in Those With Diabetes: A Case-Crossover Study
BACKGROUND: Stroke triggers are factors that may precipitate a stroke within a given time interval and can predict the timing of a stroke. While hypoglycemia has been established as a risk factor for cardiovascular events such as acute ischemic stroke (AIS), there is limited research demonstrating hypoglycemic events as stroke triggers. We hypothesize an association between hypoglycemic events and the occurrence of stroke among patients with diabetes. METHODS: We used Medicare inpatient, outpatient, emergency department, and subacute nursing facility data sets from January 1, 2016, to December 31, 2019, and validated using International Classification of Diseases , Tenth Revision , Clinical Modification codes to identify conditions. We used a case-crossover study design, testing whether exposure to a hypoglycemia encounter within progressively longer case periods (up to 30 days before index AIS) was associated with the subsequent occurrence of AIS, compared with control periods of equal length exactly 1 year before the case period. We used conditional logistical regression models to estimate odds ratios and 95% CIs. RESULTS: There were 237 667 index admissions with AIS and diabetes during the study period. There were increased odds of AIS following an encounter with hypoglycemia. The risk was the highest immediately on the first day following the hypoglycemia encounter (odds ratio, 3.694 [95% CI, 2.694–5.065]; P P <0.0001). CONCLUSIONS: We found that hypoglycemic events in patients with diabetes are associated with a more than 3-fold greater risk of AIS in the first day but can trigger AIS in the 30 days following the event. More research is needed to assess the link between the severity of hypoglycemia and stroke occurrence, as well as the severity of the stroke. These results, if confirmed in other studies, emphasize the importance of avoiding hypoglycemic events in patients with diabetes.
- Open Access
- 21 May 2024
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 10 (1) , 65-70
Racial disparities in access to, and outcomes of, acute ischaemic stroke treatments in the USA
Background Racism contributes to higher comorbid risk factors and barriers to preventive measures for black Americans. Advancements in systems of care, tissue plasminogen activator (tPA) availability and endovascular thrombectomy (ET) have impacted practice and outcomes while outpacing contemporary investigation into acute ischaemic stroke (AIS) care disparities. We examined whether recent data suggest ongoing disparity in AIS interventions and outcomes, and if hospital characteristics affect disparities. Methods We examined 2016–2019 fee-for-service Medicare inpatient data. We ran unadjusted logistic regression models to calculate ORs and 95% CI for two interventions (tPA and ET) and four outcomes (inpatient mortality, 30-day mortality, discharge home and outpatient visit within 30 days), with the main predictor black versus white race, additionally adjusting for demographics, hospital characteristics, stroke severity and comorbidities. Results 805 181 AIS admissions were analysed (12.4% black, 87.6% white). Compared with white patients, black patients had reduced odds of receiving tPA (OR 0.71, 95% CI 0.69 to 0.74, pConclusions Black patients were less likely to receive AIS treatments, and if treated had lower likelihood of 30-day mortality, discharge home and outpatient visits. Despite advancements in practice and therapies, racial disparities remain in the modern era of AIS care and are consistent with inequalities previously identified over the last 20 years. The impact of hospital attributes on AIS care disparities warrants further investigation.
- 21 May 2024
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 10 (1) , 65-70
Open AccessRacial disparities in access to, and outcomes of, acute ischaemic stroke treatments in the USA
Background Racism contributes to higher comorbid risk factors and barriers to preventive measures for black Americans. Advancements in systems of care, tissue plasminogen activator (tPA) availability and endovascular thrombectomy (ET) have impacted practice and outcomes while outpacing contemporary investigation into acute ischaemic stroke (AIS) care disparities. We examined whether recent data suggest ongoing disparity in AIS interventions and outcomes, and if hospital characteristics affect disparities. Methods We examined 2016–2019 fee-for-service Medicare inpatient data. We ran unadjusted logistic regression models to calculate ORs and 95% CI for two interventions (tPA and ET) and four outcomes (inpatient mortality, 30-day mortality, discharge home and outpatient visit within 30 days), with the main predictor black versus white race, additionally adjusting for demographics, hospital characteristics, stroke severity and comorbidities. Results 805 181 AIS admissions were analysed (12.4% black, 87.6% white). Compared with white patients, black patients had reduced odds of receiving tPA (OR 0.71, 95% CI 0.69 to 0.74, pConclusions Black patients were less likely to receive AIS treatments, and if treated had lower likelihood of 30-day mortality, discharge home and outpatient visits. Despite advancements in practice and therapies, racial disparities remain in the modern era of AIS care and are consistent with inequalities previously identified over the last 20 years. The impact of hospital attributes on AIS care disparities warrants further investigation.
- 24 April 2024
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (7) , 3991-4007
Neuropsychiatric complications of coronavirus disease 2019: Mount Sinai Health System cohort study
Objective To describe the frequency of neuropsychiatric complications among hospitalized patients with coronavirus disease 2019 (COVID-19) and their association with pre-existing comorbidities and clinical outcomes. Methods We retrospectively identified all patients hospitalized with COVID-19 within a large multicenter New York City health system between March 15, 2020 and May 17, 2021 and randomly selected a representative cohort for detailed chart review. Clinical data, including the occurrence of neuropsychiatric complications (categorized as either altered mental status [AMS] or other neuropsychiatric complications) and in-hospital mortality, were extracted using an electronic medical record database and individual chart review. Associations between neuropsychiatric complications, comorbidities, laboratory findings, and in-hospital mortality were assessed using multivariate logistic regression. Results Our study cohort consisted of 974 patients, the majority were admitted during the first wave of the pandemic. Patients were treated with anticoagulation (88.4%), glucocorticoids (24.8%), and remdesivir (10.5%); 18.6% experienced severe COVID-19 pneumonia (evidenced by ventilator requirement). Neuropsychiatric complications occurred in 58.8% of patients; 39.8% experienced AMS; and 19.0% experienced at least one other complication (seizures in 1.4%, ischemic stroke in 1.6%, hemorrhagic stroke in 1.0%) or symptom (headache in 11.4%, anxiety in 6.8%, ataxia in 6.3%). Higher odds of mortality, which occurred in 22.0%, were associated with AMS, ventilator support, increasing age, and higher serum inflammatory marker levels. Anticoagulant therapy was associated with lower odds of mortality and AMS. Conclusion Neuropsychiatric complications of COVID-19, especially AMS, were common, varied, and associated with in-hospital mortality in a diverse multicenter cohort at an epicenter of the COVID-19 pandemic.
- 24 April 2024
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (7) , 3991-4007
Neuropsychiatric complications of coronavirus disease 2019: Mount Sinai Health System cohort study
Objective To describe the frequency of neuropsychiatric complications among hospitalized patients with coronavirus disease 2019 (COVID-19) and their association with pre-existing comorbidities and clinical outcomes. Methods We retrospectively identified all patients hospitalized with COVID-19 within a large multicenter New York City health system between March 15, 2020 and May 17, 2021 and randomly selected a representative cohort for detailed chart review. Clinical data, including the occurrence of neuropsychiatric complications (categorized as either altered mental status [AMS] or other neuropsychiatric complications) and in-hospital mortality, were extracted using an electronic medical record database and individual chart review. Associations between neuropsychiatric complications, comorbidities, laboratory findings, and in-hospital mortality were assessed using multivariate logistic regression. Results Our study cohort consisted of 974 patients, the majority were admitted during the first wave of the pandemic. Patients were treated with anticoagulation (88.4%), glucocorticoids (24.8%), and remdesivir (10.5%); 18.6% experienced severe COVID-19 pneumonia (evidenced by ventilator requirement). Neuropsychiatric complications occurred in 58.8% of patients; 39.8% experienced AMS; and 19.0% experienced at least one other complication (seizures in 1.4%, ischemic stroke in 1.6%, hemorrhagic stroke in 1.0%) or symptom (headache in 11.4%, anxiety in 6.8%, ataxia in 6.3%). Higher odds of mortality, which occurred in 22.0%, were associated with AMS, ventilator support, increasing age, and higher serum inflammatory marker levels. Anticoagulant therapy was associated with lower odds of mortality and AMS. Conclusion Neuropsychiatric complications of COVID-19, especially AMS, were common, varied, and associated with in-hospital mortality in a diverse multicenter cohort at an epicenter of the COVID-19 pandemic.
- 1 April 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 17 (4) , e010388
National Institutes of Health Stroke Scale Reporting in Medicare Claims Data: Reporting in the First 3 Years
BACKGROUND: Since 2016, hospitals have been able to document International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes for the National Institutes of Health Stroke Scale (NIHSS). As of 2023, the Centers for Medicare & Medicaid Services uses NIHSS as a risk adjustment variable. We assessed associations between patient- and hospital-level variables and contemporary NIHSS reporting. METHODS: We performed a retrospective cross-sectional analysis of 2019 acute ischemic stroke admissions using deidentified, national 100% inpatient Medicare Fee-For-Service data sets. We identified index acute ischemic stroke admissions using the ICD-10-CM code I63.x and abstracted demographic information, medical comorbidities, hospital characteristics, and NIHSS. We linked Medicare and Mount Sinai Health System (New York, NY) registry data from 2016 to 2019. We calculated NIHSS documentation at the patient and hospital levels, predictors of documentation, change over time, and concordance with local data. RESULTS: There were 231 383 index acute ischemic stroke admissions in 2019. NIHSS was documented in 44.4% of admissions and by 66.5% of hospitals. Hospitals that documented ≥1 NIHSS were more commonly teaching hospitals (39.0% versus 5.5%; standardized mean difference score, 0.88), stroke certified (37.2% versus 8.0%; standardized mean difference score, 0.75), higher volume (mean, 80.8 [SD, 92.6] versus 6.33 [SD, 14.1]; standardized mean difference score, 1.12), and had intensive care unit availability (84.9% versus 23.2%; standardized mean difference score, 1.57). Adjusted odds of documentation were lower for patients with inpatient mortality (odds ratio, 0.64 [95% CI, 0.61–0.68]; P P P <0.0001). NIHSS was documented for 52.9% of Medicare cases versus 93.1% of registry cases, and 74.7% of Medicare NIHSS scores equaled registry admission NIHSS. CONCLUSIONS: Missing ICD-10-CM NIHSS data remain widespread 3 years after the introduction of the ICD-10-CM NIHSS code, and there are systematic differences in reporting at the patient and hospital levels. These findings support continued assessment of NIHSS reporting and caution in its application to risk adjustment models.
- 1 April 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 17 (4) , e010388
National Institutes of Health Stroke Scale Reporting in Medicare Claims Data: Reporting in the First 3 Years
BACKGROUND: Since 2016, hospitals have been able to document International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes for the National Institutes of Health Stroke Scale (NIHSS). As of 2023, the Centers for Medicare & Medicaid Services uses NIHSS as a risk adjustment variable. We assessed associations between patient- and hospital-level variables and contemporary NIHSS reporting. METHODS: We performed a retrospective cross-sectional analysis of 2019 acute ischemic stroke admissions using deidentified, national 100% inpatient Medicare Fee-For-Service data sets. We identified index acute ischemic stroke admissions using the ICD-10-CM code I63.x and abstracted demographic information, medical comorbidities, hospital characteristics, and NIHSS. We linked Medicare and Mount Sinai Health System (New York, NY) registry data from 2016 to 2019. We calculated NIHSS documentation at the patient and hospital levels, predictors of documentation, change over time, and concordance with local data. RESULTS: There were 231 383 index acute ischemic stroke admissions in 2019. NIHSS was documented in 44.4% of admissions and by 66.5% of hospitals. Hospitals that documented ≥1 NIHSS were more commonly teaching hospitals (39.0% versus 5.5%; standardized mean difference score, 0.88), stroke certified (37.2% versus 8.0%; standardized mean difference score, 0.75), higher volume (mean, 80.8 [SD, 92.6] versus 6.33 [SD, 14.1]; standardized mean difference score, 1.12), and had intensive care unit availability (84.9% versus 23.2%; standardized mean difference score, 1.57). Adjusted odds of documentation were lower for patients with inpatient mortality (odds ratio, 0.64 [95% CI, 0.61–0.68]; P P P <0.0001). NIHSS was documented for 52.9% of Medicare cases versus 93.1% of registry cases, and 74.7% of Medicare NIHSS scores equaled registry admission NIHSS. CONCLUSIONS: Missing ICD-10-CM NIHSS data remain widespread 3 years after the introduction of the ICD-10-CM NIHSS code, and there are systematic differences in reporting at the patient and hospital levels. These findings support continued assessment of NIHSS reporting and caution in its application to risk adjustment models.
- Open Access
- 16 January 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (2) , e029255
Provider Care Segregation and Hospital‐Region Racial Disparities in the United States for Acute Ischemic Stroke and Endovascular Therapy Outcomes
Background: Reasons for racial disparities in the use and outcomes of endovascular treatment (ET) are not known. We examined patterns in care segregation for acute ischemic stroke (AIS) in the United States, and outcomes of segregation of care after ET. Methods and Results: We used deidentified Medicare data sets to identify AIS admissions between January 1, 2016 and December 31, 2019, using validated International Classification of Diseases, Tenth Revision ( ICD‐10 ) codes. For AIS, we calculated (1) the proportion of White patients at the hospital, (2) the proportional difference in the proportion of White patients between hospital patients and the county, and (3) provider care segregation by the dissimilarity index for ET cases. Using unadjusted and adjusted multilevel logistic models, we examined associations between measures of segregation and outcomes of discharge home, inpatient mortality, and 30‐day mortality. The mean proportional difference in the proportion of White patients comparing hospitalized patients with AIS to the county race distribution was 0.015 (SD, 0.219) at the hospital level. For ET, the mean proportional difference in the proportion of White patients comparing patients receiving ET to the county race distribution was much higher, at 0.146 (SD, 0.374). The dissimilarity index for ET providers was high, with a mean of 0.48 (SD, 0.29) across all hospitals. Black patients with AIS (compared with White patients) had reduced odds of discharge home, inpatient mortality, and 30‐day mortality. Conclusions: In this national study with contemporary data in the endovascular era of AIS treatment, we found substantial evidence for segregation of care in the United States, not for only AIS in general but also especially for ET.
- 16 January 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (2) , e029255
Open AccessProvider Care Segregation and Hospital‐Region Racial Disparities in the United States for Acute Ischemic Stroke and Endovascular Therapy Outcomes
Background: Reasons for racial disparities in the use and outcomes of endovascular treatment (ET) are not known. We examined patterns in care segregation for acute ischemic stroke (AIS) in the United States, and outcomes of segregation of care after ET. Methods and Results: We used deidentified Medicare data sets to identify AIS admissions between January 1, 2016 and December 31, 2019, using validated International Classification of Diseases, Tenth Revision ( ICD‐10 ) codes. For AIS, we calculated (1) the proportion of White patients at the hospital, (2) the proportional difference in the proportion of White patients between hospital patients and the county, and (3) provider care segregation by the dissimilarity index for ET cases. Using unadjusted and adjusted multilevel logistic models, we examined associations between measures of segregation and outcomes of discharge home, inpatient mortality, and 30‐day mortality. The mean proportional difference in the proportion of White patients comparing hospitalized patients with AIS to the county race distribution was 0.015 (SD, 0.219) at the hospital level. For ET, the mean proportional difference in the proportion of White patients comparing patients receiving ET to the county race distribution was much higher, at 0.146 (SD, 0.374). The dissimilarity index for ET providers was high, with a mean of 0.48 (SD, 0.29) across all hospitals. Black patients with AIS (compared with White patients) had reduced odds of discharge home, inpatient mortality, and 30‐day mortality. Conclusions: In this national study with contemporary data in the endovascular era of AIS treatment, we found substantial evidence for segregation of care in the United States, not for only AIS in general but also especially for ET.
- 28 July 2023
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 16 (9) , 864-869
Provider care segregation and hospital-region racial disparities for carotid interventions in the USA
Background Reasons for racial disparities in the utilization and outcomes of carotid interventions (carotid endarterectomy (CEA) and carotid artery stenting (CAS)) are not well understood, especially segregation of care associated with carotid intervention. We examined patterns of geographic and provider care segregation in carotid interventions and outcomes. Method We used de-identified Medicare datasets to identify CEA and CAS interventions between January 1, 2016 and December 31, 2019 using validated ICD-10 codes. For patients who underwent carotid intervention, we calculated (1) the proportion of White patients at the hospital, (2) the proportional difference in the proportion of White patients between hospital patients and the county, and (3) provider care segregation by the dissimilarity index for carotid intervention cases. We examined associations between measures of segregation and outcomes. Results Despite higher proportions of Black patients in counties with hospitals that provide carotid intervention, lower proportions of Black patients received intervention. The difference in the proportion of White patients comparing CEA patients to the county race distribution was 0.143 (SD 0.297) at the hospital level (for CAS, 0.174 (0.315)). The dissimilarity index for CEA providers was high, with mean (SD) 0.387 (0.274) averaged across all hospitals and higher among CAS providers at 0.472 (0.288). Black patients receiving CEA and CAS (compared with Whites) had reduced odds of discharge home. Better outcomes (inpatient mortality and 30-day mortality) were independently associated with higher proportion of White CAS patients. Conclusion In this national study with contemporary data on carotid intervention, we found evidence for segregation of care of both CEA and CAS.
- 28 July 2023
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 16 (9) , 864-869
Provider care segregation and hospital-region racial disparities for carotid interventions in the USA
Background Reasons for racial disparities in the utilization and outcomes of carotid interventions (carotid endarterectomy (CEA) and carotid artery stenting (CAS)) are not well understood, especially segregation of care associated with carotid intervention. We examined patterns of geographic and provider care segregation in carotid interventions and outcomes. Method We used de-identified Medicare datasets to identify CEA and CAS interventions between January 1, 2016 and December 31, 2019 using validated ICD-10 codes. For patients who underwent carotid intervention, we calculated (1) the proportion of White patients at the hospital, (2) the proportional difference in the proportion of White patients between hospital patients and the county, and (3) provider care segregation by the dissimilarity index for carotid intervention cases. We examined associations between measures of segregation and outcomes. Results Despite higher proportions of Black patients in counties with hospitals that provide carotid intervention, lower proportions of Black patients received intervention. The difference in the proportion of White patients comparing CEA patients to the county race distribution was 0.143 (SD 0.297) at the hospital level (for CAS, 0.174 (0.315)). The dissimilarity index for CEA providers was high, with mean (SD) 0.387 (0.274) averaged across all hospitals and higher among CAS providers at 0.472 (0.288). Black patients receiving CEA and CAS (compared with Whites) had reduced odds of discharge home. Better outcomes (inpatient mortality and 30-day mortality) were independently associated with higher proportion of White CAS patients. Conclusion In this national study with contemporary data on carotid intervention, we found evidence for segregation of care of both CEA and CAS.